Droplet Microfluidics for High-sensitivity and High-throughput Detection and Screening of Disease Biomarkers

Overview

Journal Wiley Interdiscip Rev Nanomed Nanobiotechnol

Specialty Biotechnology

Date 2018 May 26

PMID 29797414

Citations 26

Authors

Aniruddha M Kaushik

Kuangwen Hsieh

Tza-Huei Wang

Affiliations

Soon will be listed here.

Abstract

Biomarkers are nucleic acids, proteins, single cells, or small molecules in human tissues or biological fluids whose reliable detection can be used to confirm or predict disease and disease states. Sensitive detection of biomarkers is therefore critical in a variety of applications including disease diagnostics, therapeutics, and drug screening. Unfortunately for many diseases, low abundance of biomarkers in human samples and low sample volumes render standard benchtop platforms like 96-well plates ineffective for reliable detection and screening. Discretization of bulk samples into a large number of small volumes (fL-nL) via droplet microfluidic technology offers a promising solution for high-sensitivity and high-throughput detection and screening of biomarkers. Several microfluidic strategies exist for high-throughput biomarker digitization into droplets, and these strategies have been utilized by numerous droplet platforms for nucleic acid, protein, and single-cell detection and screening. While the potential of droplet-based platforms has led to burgeoning interest in droplets, seamless integration of sample preparation technologies and automation of platforms from biological sample to answer remain critical components that can render these platforms useful in the clinical setting in the near future. This article is categorized under: Diagnostic Tools > Biosensing Diagnostic Tools > Diagnostic Nanodevices Therapeutic Approaches and Drug Discovery > Emerging Technologies Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease.

Citing Articles

Hyperspectral Imaging for High Throughput Optical Spectroscopy of pL Droplets.

Sulliger M, Ortega Arroyo J, Quidant R Anal Chem. 2025; 97(5):2736-2744.

PMID: 39879326 PMC: 11822737. DOI: 10.1021/acs.analchem.4c04731.

A Wettability Contrast SERS Droplet Assay for Multiplexed Analyte Detection.

Puravankara V, Manjeri A, Kulkarni M, Kitahama Y, Goda K, Dwivedi P Anal Chem. 2024; 96(22):9141-9150.

PMID: 38779970 PMC: 11154665. DOI: 10.1021/acs.analchem.4c00831.

Flexible Toolbox of High-Precision Microfluidic Modules for Versatile Droplet-Based Applications.

Saupe M, Wiedemeier S, Gastrock G, Romer R, Lemke K Micromachines (Basel). 2024; 15(2).

PMID: 38398978 PMC: 10891953. DOI: 10.3390/mi15020250.

The Multifaceted Role of FUT8 in Tumorigenesis: From Pathways to Potential Clinical Applications.

Shi M, Nan X, Liu B Int J Mol Sci. 2024; 25(2).

PMID: 38256141 PMC: 10815953. DOI: 10.3390/ijms25021068.

Identification of potential molecular mechanisms and therapeutic targets for recurrent pelvic organ prolapse.

Zhou Q, Lu M, Li G, Peng G, Song Y Heliyon. 2023; 9(9):e19440.

PMID: 37681155 PMC: 10481308. DOI: 10.1016/j.heliyon.2023.e19440.

References

Li M, Diehl F, Dressman D, Vogelstein B, Kinzler K . BEAMing up for detection and quantification of rare sequence variants. Nat Methods. 2006; 3(2):95-7. DOI: 10.1038/nmeth850. View

Rinaldi A . Teaming up for biomarker future. Many problems still hinder the use of biomarkers in clinical practice, but new public-private partnerships could improve the situation. EMBO Rep. 2011; 12(6):500-4. PMC: 3128290. DOI: 10.1038/embor.2011.90. View

Hatch A, Fisher J, Pentoney S, Yang D, Lee A . Tunable 3D droplet self-assembly for ultra-high-density digital micro-reactor arrays. Lab Chip. 2011; 11(15):2509-17. DOI: 10.1039/c0lc00553c. View

Trypsteen W, Kiselinova M, Vandekerckhove L, De Spiegelaere W . Diagnostic utility of droplet digital PCR for HIV reservoir quantification. J Virus Erad. 2016; 2(3):162-9. PMC: 4967968. View

Mukaide M, Sugiyama M, Korenaga M, Murata K, Kanto T, Masaki N . High-throughput and sensitive next-generation droplet digital PCR assay for the quantitation of the hepatitis C virus mutation at core amino acid 70. J Virol Methods. 2014; 207:169-77. DOI: 10.1016/j.jviromet.2014.07.006. View

Syme C, Martino C, Yusvana R, Sirimuthu N, Cooper J . Quantitative characterization of individual microdroplets using surface-enhanced resonance Raman scattering spectroscopy. Anal Chem. 2012; 84(3):1491-5. DOI: 10.1021/ac202705a. View

Postek W, Kaminski T, Garstecki P . A passive microfluidic system based on step emulsification allows the generation of libraries of nanoliter-sized droplets from microliter droplets of varying and known concentrations of a sample. Lab Chip. 2017; 17(7):1323-1331. DOI: 10.1039/c7lc00014f. View

Guan W, Chen L, Rane T, Wang T . Droplet Digital Enzyme-Linked Oligonucleotide Hybridization Assay for Absolute RNA Quantification. Sci Rep. 2015; 5:13795. PMC: 4558716. DOI: 10.1038/srep13795. View

Pekin D, Skhiri Y, Baret J, Le Corre D, Mazutis L, Salem C . Quantitative and sensitive detection of rare mutations using droplet-based microfluidics. Lab Chip. 2011; 11(13):2156-66. DOI: 10.1039/c1lc20128j. View

10.

Zhu Y, Fang Q . Analytical detection techniques for droplet microfluidics--a review. Anal Chim Acta. 2013; 787:24-35. DOI: 10.1016/j.aca.2013.04.064. View

11.

Aronson J . Biomarkers and surrogate endpoints. Br J Clin Pharmacol. 2005; 59(5):491-4. PMC: 1884846. DOI: 10.1111/j.1365-2125.2005.02435.x. View

12.

Xu P, Zheng X, Tao Y, Du W . Cross-Interface Emulsification for Generating Size-Tunable Droplets. Anal Chem. 2016; 88(6):3171-7. DOI: 10.1021/acs.analchem.5b04510. View

13.

Takahama T, Sakai K, Takeda M, Azuma K, Hida T, Hirabayashi M . Detection of the T790M mutation of EGFR in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study). Oncotarget. 2016; 7(36):58492-58499. PMC: 5295446. DOI: 10.18632/oncotarget.11303. View

14.

Boehme C, Nabeta P, Hillemann D, Nicol M, Shenai S, Krapp F . Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010; 363(11):1005-15. PMC: 2947799. DOI: 10.1056/NEJMoa0907847. View

15.

Rondelez Y, Tresset G, Tabata K, Arata H, Fujita H, Takeuchi S . Microfabricated arrays of femtoliter chambers allow single molecule enzymology. Nat Biotechnol. 2005; 23(3):361-5. DOI: 10.1038/nbt1072. View

16.

Liu X, Painter R, Enesa K, Holmes D, Whyte G, Garlisi C . High-throughput screening of antibiotic-resistant bacteria in picodroplets. Lab Chip. 2016; 16(9):1636-43. DOI: 10.1039/c6lc00180g. View

17.

Najah M, Mayot E, Mahendra-Wijaya I, Griffiths A, Ladame S, Drevelle A . New glycosidase substrates for droplet-based microfluidic screening. Anal Chem. 2013; 85(20):9807-14. DOI: 10.1021/ac4022709. View

18.

Ding Y, Casadevall I Solvas X, DeMello A . "V-junction": a novel structure for high-speed generation of bespoke droplet flows. Analyst. 2014; 140(2):414-21. DOI: 10.1039/c4an01730g. View

19.

Clausell-Tormos J, Lieber D, Baret J, El-Harrak A, Miller O, Frenz L . Droplet-based microfluidic platforms for the encapsulation and screening of Mammalian cells and multicellular organisms. Chem Biol. 2008; 15(5):427-37. DOI: 10.1016/j.chembiol.2008.04.004. View

20.

Watanabe M, Kawaguchi T, Isa S, Ando M, Tamiya A, Kubo A . Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR. Clin Cancer Res. 2015; 21(15):3552-60. DOI: 10.1158/1078-0432.CCR-14-2151. View